Real-World Comparative Effectiveness of Second-Line Ipilimumab for Metastatic Melanoma: A Population-Based Cohort Study in Ontario, Canada

BMC Cancer - United Kingdom
doi 10.1186/s12885-020-06798-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Thyroid Cancer Incidence Among Asian Immigrants to Ontario, Canada: A Population-Based Cohort Study

Cancer
Cancer ResearchOncology
2017English

Relationship Between Life Satisfaction and Preventable Hospitalisations: A Population-Based Cohort Study in Ontario, Canada

BMJ Open
Medicine
2020English

Comparative Effectiveness of Early-Line Nab-Paclitaxel vs. Paclitaxel in Patients With Metastatic Breast Cancer: A US Community-Based Real-World Analysis

Cancer Management and Research
Oncology
2018English

‘Real-World’ Effectiveness of Smoking Cessation Treatments: A Population Study

Addiction
MedicinePsychiatryMental Health
2013English

Pcn2 - Effectiveness and Safety of Pembrolizumab in Advanced or Metastatic Melanoma: Preliminary Results From Real World

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Stable Rates of Operative Treatment of Distal Radius Fractures in Ontario, Canada: A Population-Based Retrospective Cohort Study (2004–2013)

Canadian Journal of Surgery
MedicineSurgery
2019English

Contributions of Prescribed and Non-Prescribed Opioids to Opioid Related Deaths: Population Based Cohort Study in Ontario, Canada

British Medical Journal
Medicine
2018English

Bevacizumab Plus Ipilimumab in Patients With Metastatic Melanoma

Cancer immunology research
Cancer ResearchImmunology
2014English

Ipilimumab: An Anti-Ctla-4 Antibody for Metastatic Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy